Response
- 31 March 1993
- journal article
- editorial
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 46 (3) , 319-321
- https://doi.org/10.1016/0895-4356(93)90083-d
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Bias in meta-analytic researchJournal of Clinical Epidemiology, 1992
- Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefitJournal of Clinical Epidemiology, 1992
- SHOULD DISEASE-MODIFYING AGENTS BE USED IN MILD RHEUMATOID ARTHRITIS?Rheumatology, 1991
- The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis results of two metaanalysesArthritis & Rheumatism, 1990
- COMBINATION THERAPY WITH GOLD AND HYDROXYCHLOROQUINE IN RHEUMATOID ARTHRITIS: A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED STUDYRheumatology, 1989
- Auranofin (SK&F) in Early Rheumatoid Arthritis: Results from a 24-month Double-blind, Placebo-controlled StudyEffect on Clinical and Biochemical AssessmentsScandinavian Journal of Rheumatology, 1989
- Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritisClinical Rheumatology, 1984